Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefiderocol versus imipenem/cilastatin for complicated urinary tract infection in Chinese adults
ChiCTR2400090538Phase 3Completed
- Sponsor
- Huashan Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cefiderocol in complicated urinary tract infection (cUTI) and pyelonephritis (2 arms), sponsored by Huashan Hospital. Primary endpoint: Composite response at test of cure. Started Oct 2024; status: completed.
02
Drugs
cefiderocol
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on ChiCTR2400090538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090538.